Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04854564 · ClinicalTrials.gov registry record
Identifying Perceived Barriers and Facilitators Toward a Liver Transplantation Prehabilitation
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 114
- Enrollment target
NCT04854564: Completed study, sponsored by University of Alabama at Birmingham.
NCT04854564 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 114 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04854564 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
Study Summary
The purpose of this study is to formally identify patient and caregiver perceived needs, barriers, and facilitators to inform the development of a home-based multimodal prehabilitation program for potential LT candidates.
Primary Outcome
Change from baseline in liver frailty index score at 3 months; the higher LFI scores indicate a higher degree of frailty. LFI\<3.2: robust, LFI=3.2-4.4: prefrail, LFI\>=4.5: Frail.
Interventions
- BEHAVIORAL Prehabilitation intervention
- BEHAVIORAL Caregiver intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2023-04-28 |
What the finished NCT04854564 record still lists
NCT04854564 is an observational study that tracks outcomes without assigning an intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Prehabilitation intervention is the first listed.
NCT04854564 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04854564 about?
NCT04854564 is a clinical study titled "Identifying Perceived Barriers and Facilitators Toward a Liver Transplantation Prehabilitation". The purpose of this study is to formally identify patient and caregiver perceived needs, barriers, and facilitators to inform the development of a home-based multimodal prehabilitation program for potential LT candidates.
What is the current status of trial NCT04854564?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2021-08-01. Estimated completion is 2023-04-28.
What interventions are being tested in trial NCT04854564?
The interventions under investigation include: Prehabilitation intervention (BEHAVIORAL), Caregiver intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04854564?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI